Literature DB >> 22727724

Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence.

Nicolas F Turek1, Ana C Ricardo, James P Lash.   

Abstract

Despite the high prevalence and enormous public health implications of chronic kidney disease (CKD), the factors responsible for its development and progression are incompletely understood. To date, only a few studies have attempted to objectively characterize sleep in patients with CKD prior to kidney failure, but emerging evidence suggests a high prevalence of sleep disorders, particularly obstructive sleep apnea. Laboratory and epidemiologic studies have shown that insufficient sleep and poor sleep quality promote the development and exacerbate the severity of 3 important risk factors for CKD, namely hypertension, type 2 diabetes, and obesity. In addition, sleep disturbances might have a direct effect on CKD through chronobiological alterations in the renin-angiotensin-aldosterone system and sympathetic nervous system activation. The negative impact of sleep disorders on vascular compliance and endothelial function also may have a deleterious effect on CKD. Sleep disturbances therefore may represent a novel risk factor for the development and progression of CKD. Optimizing sleep duration and quality and treating sleep disorders may reduce the severity and delay the progression of CKD.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727724      PMCID: PMC3461247          DOI: 10.1053/j.ajkd.2012.04.027

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  74 in total

1.  Time-courses in renin and blood pressure during sleep in humans.

Authors:  A Charloux; F Piquard; J Ehrhart; B Mettauer; B Geny; C Simon; G Brandenberger
Journal:  J Sleep Res       Date:  2002-03       Impact factor: 3.981

2.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation.

Authors: 
Journal:  J Am Soc Nephrol       Date:  2001-06       Impact factor: 10.121

3.  Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients.

Authors:  M Valencia-Flores; A Orea; V A Castaño; M Resendiz; M Rosales; V Rebollar; V Santiago; J Gallegos; R M Campos; J González; J Oseguera; G García-Ramos; D L Bliwise
Journal:  Obes Res       Date:  2000-05

4.  Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Carmen A Peralta; David R Jacobs; Ronit Katz; Joachim H Ix; Magdalena Madero; Daniel A Duprez; Mark J Sarnak; Michael H Criqui; Holly J Kramer; Walter Palmas; David Herrington; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2011-10-14       Impact factor: 8.860

5.  Prospective study of the association between sleep-disordered breathing and hypertension.

Authors:  P E Peppard; T Young; M Palta; J Skatrud
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

6.  Inverse coupling between ultradian oscillations in delta wave activity and heart rate variability during sleep.

Authors:  G Brandenberger; J Ehrhart; F Piquard; C Simon
Journal:  Clin Neurophysiol       Date:  2001-06       Impact factor: 3.708

7.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

8.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

9.  Proteinuria in obstructive sleep apnea.

Authors:  L F Casserly; N Chow; S Ali; D J Gottlieb; L J Epstein; J S Kaufman
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

10.  Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders.

Authors:  R L Benz; M R Pressman; E T Hovick; D D Peterson
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

View more
  55 in total

1.  Obstructive Sleep Apnea, Other Sleep Characteristics, and Risk of CKD in the Atherosclerosis Risk in Communities Sleep Heart Health Study.

Authors:  Kelsie M Full; Chandra L Jackson; Casey M Rebholz; Kunihiro Matsushita; Pamela L Lutsey
Journal:  J Am Soc Nephrol       Date:  2020-06-26       Impact factor: 10.121

2.  Renoprotective effects of continuous positive airway pressure in chronic kidney disease patients with sleep apnea.

Authors:  Robert Puckrin; Sameena Iqbal; Arnold Zidulka; Murray Vasilevsky; Paul Barre
Journal:  Int Urol Nephrol       Date:  2015-09-30       Impact factor: 2.370

3.  Association of short sleep duration and rapid decline in renal function.

Authors:  Ciaran J McMullan; Gary C Curhan; John P Forman
Journal:  Kidney Int       Date:  2016-03-25       Impact factor: 10.612

Review 4.  Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship?

Authors:  Bisher Abuyassin; Kumar Sharma; Najib T Ayas; Ismail Laher
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

5.  Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.

Authors:  Reiko Okubo; Masahide Kondo; Shu-ling Hoshi; Kunihiro Yamagata
Journal:  Sleep Breath       Date:  2015-02-03       Impact factor: 2.816

6.  Sleep and CKD in Chinese Adults: A Cross-Sectional Study.

Authors:  Junjuan Li; Zhe Huang; Jinhong Hou; Amy M Sawyer; Zhijun Wu; Jianfang Cai; Gary Curhan; Shouling Wu; Xiang Gao
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-07       Impact factor: 8.237

7.  Intrarenal hemodynamic and oxidative stress in patients with obstructive sleep apnea syndrome.

Authors:  L Sardo; P Palange; F Di Mario; B Barbano; A Gigante; M Mordenti; A Steffanina; M Bonini; A Amoroso; F Vaccaro; R Cianci
Journal:  Sleep Breath       Date:  2015-04-01       Impact factor: 2.816

8.  A prospective cohort study of insomnia and chronic kidney disease in Japanese workers.

Authors:  Sachiko Sasaki; Eiji Yoshioka; Yasuaki Saijo; Akira Bannai; Toshiko Kita; Akiko Tamakoshi; Reiko Kishi
Journal:  Sleep Breath       Date:  2017-05-22       Impact factor: 2.816

9.  Sleep Quality and Sleep Duration with CKD are Associated with Progression to ESKD.

Authors:  Ryohei Yamamoto; Maki Shinzawa; Yoshitaka Isaka; Etsuko Yamakoshi; Enyu Imai; Yasuo Ohashi; Akira Hishida
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-15       Impact factor: 8.237

10.  Sleep Duration and Health-Related Quality of Life in Predialysis CKD.

Authors:  Su-Ah Sung; Young Youl Hyun; Kyu Beck Lee; Hayne Cho Park; Wookyung Chung; Yeong Hoon Kim; Yong-Soo Kim; Sue Kyung Park; Kook-Hwan Oh; Curie Ahn
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.